Takara BIO USA, INC.:1109645 [19-004308]

Ended Purchase Order Awarded Last action

Contract number
75N90019P00219
Awardee
Awarding agency
Obligated
$188,758

Award facts

Opportunity
Contract value 100% obligated
$188,757.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Mountain View, CA 94043, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The NIH Clinical Center issued a purchase order to Takara Bio USA, Inc. for $188,757.80 on February 21, 2019, with completion by September 30, 2019. Performance occurs in Mountain View, California. The order procures biomedical research products and life sciences tools, likely reagents or kits for clinical and research applications based on the vendor's product portfolio of biological reagents, diagnostic kits, and laboratory instruments. The solicitation was posted January 28, 2019 with bids due February 12, 2019.

Quick answers

Who was awarded contract 75N90019P00219?

75N90019P00219 was awarded to Takara Bio Usa, Inc. by NIH Clinical Center (National Institutes of Health) on February 21, 2019.

How much is contract 75N90019P00219 worth?

The government has obligated $188,758 on 75N90019P00219.

Was contract 75N90019P00219 competed?

The extent of competition for 75N90019P00219 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login